Evidence map›Paper›PMID 38264204›Full record

ArticleOxford medical case reports2023

Severe and fatal interstitial lung disease induced by gemcitabine in advanced pancreatic adenocarcinoma: a case report.

Edwin Kelly Haag, Ganiou Adjadé, Héba Dawood, Mohammed El Fadli, Ismail Essadi, Rhizlane Belbaraka

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxford medical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Edwin Kelly HaagDepartment of Medical Oncology, University Hospital Mohammed VI, Cadi Ayyad University, Marrakech, Morocco.
Ganiou AdjadéDepartment of Medical Oncology, University Hospital Mohammed VI, Cadi Ayyad University, Marrakech, Morocco.
Héba DawoodDepartment of Medical Oncology, Regional Hospital of Orleans, Orleans, France.
Mohammed El FadliDepartment of Medical Oncology, University Hospital Mohammed VI, Cadi Ayyad University, Marrakech, Morocco.
Ismail EssadiDepartment of Medical Oncology, Military Hospital Avicennes, Marrakech, Morocco.
Rhizlane BelbarakaDepartment of Medical Oncology, University Hospital Mohammed VI, Cadi Ayyad University, Marrakech, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gemcitabine is a cytotoxic drug commonly used in the treatment of several types of cancer. While gemcitabine is generally considered safe and effective, it can cause some side effects, including pulmonary toxicity. Interstitial lung disease is a rare but potentially serious event. We report a case of a 63-year-old patient with advanced pancreatic adenocarcinoma. She received Gemcitabine 1000 mg/m

Identifiers

PMID38264204
PMCPMC10805609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.